CIK 0002130606 · Non-accelerated filer<br>Emerging growth company
Obsidian Therapeutics, Inc.
Sign in to watch- Ticker
- OBX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 421977778
- Phone
- (781) 806-6245
- Business address
- 1030 MASSACHUSETTS AVENUE, CAMBRIDGE, MA, 02138
- Former names
- Gazelle Parent, Inc.
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- S-8 Other Securities Offered to Employees in Benefit Plans
- 8-K Event Material agreement · Acquisition or sale completed · Results of operations · Unregistered share sale · Shareholder rights changed · Auditor change · Change in control · Executive or director change · Bylaws or fiscal year change · Regulation FD disclosure
- CERT Other Certification
- 8-A12B/A Other Registration Statement
- 8-A12B Other Registration of Securities
- EFFECT Other Notice of Effectiveness
- 424B3 Offering Prospectus
- S-4/A Deal Registration Statement - Business Combination
- S-4/A Deal Registration Statement - Business Combination
- S-4/A Deal Registration Statement - Business Combination
- S-4/A Deal Registration Statement - Business Combination
- S-4 Deal Registration Statement - Business Combination
Page 2 of 2 · 35 filings